美國賣得最好的二十種藥 - 醫療資訊
By Charlie
at 2004-10-01T06:33
at 2004-10-01T06:33
Table of Contents
轉載自 newyor times
A List of the Best-Selling Drugs in U.S
By THE ASSOCIATED PRESS
Published: September 30, 2004
Filed at 3:44 p.m. ET
The top selling drugs in the United States in 2003, their annual sales,
what it treats and its manufacturer. The 2003 data is the most recent
audited figures available.
藥名 營收 用途 公司
1. Lipitor, $6.8 billion, cholesterol, Pfizer Inc.
2. Zocor, $4.4 billion, cholesterol, Merck & Co.
3. Prevacid, $4.0 billion, heartburn, TAP Pharmaceutical Products Inc.
4. Procrit, $3.3 billion, anemia, Johnson & Johnson
5. Zyprexa, $3.2 billion, mental illness, Eli Lilly & Co.
6. Epogen, $3.1 billion, anemia, Amgen Inc.
7. Nexium, $3.1 billion, heartburn, Merck & Co.
8. Zoloft, $2.9 billion, depression, Pfizer Inc.
9. Celebrex, $2.6 billion, arthritis, Pfizer Inc.
10. Neurontin, $2.4 billion, epilepsy, Pfizer Inc.
11. Advair Diskus, $2.3 billion, asthma, GlaxoSmithKline PLC
12. Plavix, $2.2 billion, blood clots, Bristol-Myers Squibb Co.
13. Norvasc, $2.2 billion, high blood pressure, Pfizer Inc.
14. Effexor XR, $2.1 billion, depression, Wyeth
15. Pravachol, $2.0 billion, cholesterol, Bristol-Myers Squibb Co.
16. Risperdal, $2.0 billion, mental illness, Johnson & Johnson
17. Oxycontin, $1.9 billion, pain, Perdue Pharma
18. Fosamax, $1.8 billion, osteoporosis, Merck & Co.
19. Protonix, $1.8 billion, gastrointestinal reflux disease, Wyeth
20. Vioxx, $1.8 billion, arthritis, Merck & Co.
--
有醫療問題歡迎至 http://bbs.keinmal.idv.tw 討論
--
A List of the Best-Selling Drugs in U.S
By THE ASSOCIATED PRESS
Published: September 30, 2004
Filed at 3:44 p.m. ET
The top selling drugs in the United States in 2003, their annual sales,
what it treats and its manufacturer. The 2003 data is the most recent
audited figures available.
藥名 營收 用途 公司
1. Lipitor, $6.8 billion, cholesterol, Pfizer Inc.
2. Zocor, $4.4 billion, cholesterol, Merck & Co.
3. Prevacid, $4.0 billion, heartburn, TAP Pharmaceutical Products Inc.
4. Procrit, $3.3 billion, anemia, Johnson & Johnson
5. Zyprexa, $3.2 billion, mental illness, Eli Lilly & Co.
6. Epogen, $3.1 billion, anemia, Amgen Inc.
7. Nexium, $3.1 billion, heartburn, Merck & Co.
8. Zoloft, $2.9 billion, depression, Pfizer Inc.
9. Celebrex, $2.6 billion, arthritis, Pfizer Inc.
10. Neurontin, $2.4 billion, epilepsy, Pfizer Inc.
11. Advair Diskus, $2.3 billion, asthma, GlaxoSmithKline PLC
12. Plavix, $2.2 billion, blood clots, Bristol-Myers Squibb Co.
13. Norvasc, $2.2 billion, high blood pressure, Pfizer Inc.
14. Effexor XR, $2.1 billion, depression, Wyeth
15. Pravachol, $2.0 billion, cholesterol, Bristol-Myers Squibb Co.
16. Risperdal, $2.0 billion, mental illness, Johnson & Johnson
17. Oxycontin, $1.9 billion, pain, Perdue Pharma
18. Fosamax, $1.8 billion, osteoporosis, Merck & Co.
19. Protonix, $1.8 billion, gastrointestinal reflux disease, Wyeth
20. Vioxx, $1.8 billion, arthritis, Merck & Co.
--
有醫療問題歡迎至 http://bbs.keinmal.idv.tw 討論
--
Tags:
醫療資訊
All Comments
Related Posts
請推薦台中榮總的骨科醫生
By Bethany
at 2004-09-30T02:12
at 2004-09-30T02:12
Re: 關於過敏
By Puput
at 2004-09-14T13:22
at 2004-09-14T13:22
請問桃園中壢地區的中醫生
By Daph Bay
at 2004-09-12T09:22
at 2004-09-12T09:22
自費心臟超音波
By Gilbert
at 2004-09-11T13:26
at 2004-09-11T13:26
未注射B肝疫苗?
By Leila
at 2004-09-09T17:26
at 2004-09-09T17:26